PRESS RELEASE BY
THE INKATHA FREEDOM PARTY


MEDICINE PRICES

Durban: 17 February 2004

The draft regulations on medicine prices form one part of a larger process dealing with medicine supplies in the country. In its entity, the Act regulates import, export, production, sales, safety, quality and efficacy of medicines.

All aspects of the law give draconian powers to the Minister and her Director-General to engineer and to control. In the case of medicine sales, the Director-General may overrule any price charged by a manufacturer for a medicine, having acquired a host of information about the production costs and international prices. He or she is bound to make horrendous mistakes.

The initial price is set at 50% of the current price. This is an absurdly arbitrary figure that does not take into account the fairness or otherwise of the current medicine price. Furthermore, as the government forces down
costs to the private sector, they will go up for the State.

Since the industry is often guilty of inflating and manipulating prices, enforcing transparency along the entire chain of supply is a necessary evil. But the complexity of the add on calculations at each level of the chain
will be impossible for smaller companies to implement. It will require sophisticated computing and will be very difficult to monitor. It adds another layer of beaurocracy and cost to those who deal in medicines.

The result is not to improve access to the poor, or to reduce the health spend or to equalise services. Sophisticated new medicine will not be available to anyone and state supplies will be even further reduced due to the price strain. It is frustrating that most companies and associations affected are too scared to complain. They are beholden to government for approval in everything they do. They dare not be seen to be opponents of the system.

Welcome to a one-party state.

The IFP advocates communication with and participation by the industry, transparency, better policing of corrupt practices and tight controls to minimise theft and sale of counterfeit medicines.


Contact.
Dr Ruth Rabinowitz